Client News

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

G.ST Antivirals reports positive Phase I trial results for 2-Deoxy-D-glucose against upper respiratory infections

AiCuris and the German Center for Infection Research (DZIF) sign Collaboration and License Option Agreement

Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024

BioLizard announces Swiss subsidiary and service offering for AI-powered digital transformation of life sciences at Biopôle in Lausanne

Abivax provides 2024 strategic outlook and lays out key milestones over next 12 months

Kizoo leads financing round in Reservoir Neuroscience to restore health to the aging brain

Affluent Medical: Pre-submission dossier for the 510(k) of medical device Kalios filed with FDA for review

Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium

Mainz Biomed Provides Year-End Corporate Review 2023